Tag Archives: AAT

Landmark clinical trial validates efficacy of treatment for genetically caused emphysema.

A landmark clinical study from researchers at the Toronto Western Hospital provides convincing evidence that a frequently overlooked therapy for genetically-caused emphysema is effective at slowing the progression of the disease.  The team explain that Alpha-1 Antitrypsin deficiency is an inherited disorder that can cause emphysema even without exposure to tobacco smoke. Alpha-1 antitrypsin (AAT) is a protein made in

Read more